Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.02 CAD | 0.00% | 0.00% | -20.00% |
Business Summary
Sales per Business
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biopharmaceutical
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -66.95% |
Sales per region
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United Kingdom
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -66.95% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Larry Thiessen
CEO | Chief Executive Officer | - | 01/20/01 |
Haaris Uddin
DFI | Director of Finance/CFO | - | 01/19/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Albert Friesen
CHM | Chairman | 77 | 14/16/14 |
P. Enns
BRD | Director/Board Member | 52 | 14/16/14 |
Larry Thiessen
CEO | Chief Executive Officer | - | 01/20/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 54,000,000 | 13,608,000 ( 25.20 %) | 0 | 25.20 % |
Company contact information
Waverley Pharma, Inc.
1250 Waverley Street Suite No. 4
R3T 6C6, Winnipeg
+204-928-7907
http://www.waverleypharma.comSector
Sales per region
1st Jan change | Capi. | |
---|---|---|
-20.00% | 794K | |
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.87B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- WAVE Stock
- Company Waverley Pharma Inc.